A cysteine residue located in the transmembrane domain of CD44 is important in binding of CD44 to hyaluronic acid

Journal of Experimental Medicine

Volumn 183, Issue 5, 1996, Pages 1987-1994

  Liu, Dacai ^a   Sy, Man Sun ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; CYSTEINE; HERMES ANTIGEN; HYALURONIC ACID; MONOCLONAL ANTIBODY CD3;

AMINO ACID SUBSTITUTION; ARTICLE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LIGAND BINDING; PRIORITY JOURNAL; PROTEIN DOMAIN; SITE DIRECTED MUTAGENESIS; STRUCTURE ACTIVITY RELATION;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, CD; ANTIGENS, CD44; BINDING SITES; CELL LINE; CELL MEMBRANE; CLONING, MOLECULAR; CONSERVED SEQUENCE; CYSTEINE; CYTOPLASM; HUMANS; HYALURONIC ACID; KINETICS; MAMMALS; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; RECOMBINANT PROTEINS; TRANSFECTION;

EID: 0029904110     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.183.5.1987     Document Type: Article

References (47)

1. Haynes, B.F., M.J. Telen, L.P. Hale, and S.M. Denning. 1989. CD44 a molecule involved in leukocyte adherence and T cell activation. Immunol. Today. 10:423-428.
2. Underhill, C. 1992. CD44: The hyaluronan receptor. J. Cell Sci. 103:293-298.
3. Lesley, J., R. Hyman, and P.W. Kincade. 1993. CD44 and its interaction with extracellular matrix. Adv. in Immunol. 54: 271-335.
4. Herrlich, P., M. Zoller, S.T. Pals, and H. Ponta. 1993. CD44 splice variants: metastases meet lymphocytes. Immunol. Today. 14:395-399.
5. Stamenkovic, I., M. Amiot, J.M. Pesando, and B. Seed. 1989. A lymphocyte molecule implicated in lymph node homing is a membrane of the cartilage link protein family. Cell. 56: 1057-1062.
6. Goldstein, L.A., D.F.H. Zhou, L.J. Picker, C.N. Minty, R.F. Bargatze, J.F. Ding, and E.C. Butcher. 1989. A human lymphocyte homing receptor the hermes antigen, is related to cartilage proteoglycan core and link proteins. Cell. 56:1063-1072.
7. Zhou, D.F.H., J.F. Ding, L.J. Picker, R.F. Bargatze, E.C. Butcher, and D.V. Goeddel. 1989. Cloning and expression of Pgp-1. J. Immunol. 143:3390-3395.
8. Screaton, G.R., M.V. Bell, D.G. Jackson, F.B. Cornelis, U. Gerth, and J.I. Bell. 1992. Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. Proc. Natl. Acad. Sci. USA. 89: 12160-12164.
9. Miyake, K., C.B. Underhill, J. Lesley, and P.W. Kincade. 1990. Hyaluronate can function as a cell adhesion molecule and CD44 participates in hyaluronate recognition. J. Exp. Med. 172:69-75.
10. Aruffo, A., I. Stamenkovic, M. Melnick, C.B. Underhill, and B. Seed. 1990. CD44 is the principal cell surface receptor for hyaluronate. Cell. 61:1303-1313.
11. Lesley, J., R. Schulte, and R. Hyman. 1990. Binding of hyaluronic acid to lymphoid cell lines is inhibited by monoclonal antibodies against Pgp-1. J. Exp. Cell. Res. 187:224-233.
12. The Biology of Hyaluronan. Ciba Foundation Symposium 143. 1989. John Wiley and Sons Ltd. New York. 287 pp.
13. Laurent, T.C., and J.R.E. Fraser. 1992. Hyaluronan. FASEB. J. 6:2397-2404.
14. Peach, R.J., D. Hollenbaugh, and I. Stamenkovic. 1993. Identification of hyaluronic acid binding sites in the extracellular domain of CD44. J. Cell Biol. 122:257-264.
15. Liao, H.X., D.M. Lee, M.C. Levesque, and B.F. Haynes. 1995. N-terminal and central regions of the human CD44 extracellular domain participate in cell surface hyaluronan binding. J. Immunol. 155:3938-3945.
16. Sy, M.S., D. Liu, R. Schiavone, J. Ma, H. Mori, and Y.J. Guo. 1996. Interactions between CD44 and hyaluronic acid; their role in tumor growth and metastasis. In Attempts to Understand Metastasis Formation. Current Topics in Microbiology and Immunology. U. Schiag and P.W. Birchmeir, editors. Springer-Verlag. 113-137.
17. Hathcock, K.S., H. Hirano, S. Murakaini, and R.J. Hodes. 1993. CD44 expression on activated B cells. Differential capacity for CD44 dependent binding to hyaluronic acid. J. Immunol. 151:6712-6722.
18. Liao, H.X., M.C. Levesque, K. Patton, B. Bergamo, D. Jones, M.A. Moody, M.J. Telen, and B.F. Haynes. 1993. Regulation of human CD44H and CD44E isoform binding to hyaluronan by phorbol myristate acetate and anti-CD44 monoclonal and polyclonal antibodies. J. Immunol. 151:6490-6499.
19. Lesley, J., Q. He, K. Miyake, A. Hamann, R. Hyman, and P.W. Kincade. 1992. Requirements for hyaluronic acid binding by CD44: a role for the cytoplasmic domain and activation by antibody. J. Exp. Med. 175:257-266.
20. Katoh, S., Z. Zheng, K. Ontani, T. Shimozato, and P.W. Kincade. 1995. Glycosylation of CD44 negatively regulates its recognition of hyaluronan. J. Exp. Med. 182:419-429.
21. Lesley, J., N. English, A. Perschl, J. Gregoroff, and R. Hyman. 1995. Variant cell lines selected for alterations in the function of the hyaluronan receptor CD44 show differences in glycosylation. J. Exp. Med. 182:431-437.
22. Kogerman, P., M.S. Sy, and L.A. Culp. 1995. Oncogene dependent expression of CD44 in Balb/c 3T3 derivatives: correlation with metastatic competence. Clin. Exp. Metast. In press.
23. Tarone, G., R. Ferracini, G. Galetto, and A.P. Comoglio. 1984. A cell surface integral membrane glycoprotein of 85,000 molecular weight associated with Triton X-100 insoluble cell skeleton. J. Cell. Biol. 99:512-519.
24. Jacobson, K., D. O'Dell, and J.T. August. 1984. Lateral diffusion of an 80,000 dalton glycoprotein in the plasma membrane of murine fibroblasts: relationship to cell structure and function. J. Cell Biol. 99:1624-1633.
25. Lacy, B.E., and C.B. Underhill. 1987. The hyaluronate receptor is associated with actin filaments. J. Cell. Biol. 105: 1395-1404.
26. Kalomiris, E.L., and L.Y.W. Bourguignon. 1988. Mouse T lymphoma cells contain a transmembrane glycoprotein (GP85) that binds ankyrin. J. Cell. Biol. 106:319-327.
27. Luna, E.J., and L.A. Hitt. 1992. Cytoskeletal plasma membrane interactions. Science (Wash. DC). 258:955-964.
28. Isacke, C.M. 1994. The role of the cytoplasmic domain in regulating CD44 function. J. Cell Sci. 107:2353-2359.
29. Perschl, A., J. Lesley, N. English, I. Trowbridge, and R. Hyman. 1995. Role of CD44 cytoplasmic domain in hyaluronan binding. Eur. J. Immunol. 25:495-501.
30. Murakami, S., Y. Shimabukuro, Y. Miki, T. Saho, E. Hind, D. Kasai, T. Nozaki, Y. Kusumoto, and H. Okada. 1994. Inducible binding of human lymphocytes to hyaluronate via CD44 does not require cytoskeleton association but does require new protein synthesis. J. Immunol. 152:467-477.
31. Lokeshwar, V.B., N. Fregien, and L.Y.W. Bourguignon. 1994. Ankyrin-binding domain of CD44(GP85) is required for the expression of hyaluronic acid mediated adhesion function. J. Cell Biol. 126:1099-1109.
32. Pure, E., R.L. Camp, D. Peritt, R.A. Panettieri, A.L. Lazaar, and S. Nayak. 1995. Defective phosphorylation and hyaluronate binding of CD44 with point mutations in the cytoplasmic domain. J. Exp. Med. 181:55-62.
33. Lokeshwar, V.B., and L.Y.W. Bourguignon. 1992. The lymphoma transmembrane glycoprotein GP85(CD44) is a novel guanine nucleotide-binding protein which regulates GP85 ankyrin interaction. J. Biol. Chem. 267:22073-22078.
34. Underhill, C.B. 1982. Interaction of hyaluronate with the surface of simian virus 4-transformed 3T3 cells. Aggregation and binding studies. J. Cell Sci. 56:177-189.
35. Underbill, C.B., G. Chi-Rosso, and B.P. Toole. 1983. Effects of detergent solubilization on the hyaluronate-binding protein from membranes of simian virus 40 transformed 3T3 cells. J. Biol. Chem, 258:8086-8091.
36. Olson, E.N., and G. Spizz. 1986. Fatty acylation of cellular proteins. J. Biol. Chem. 261:2458-2466.
37. Sefton, B.M., and J.E. Buss. 1987. The covalent modification of eucaryotic proteins with lipid. J. Cell Biol. 104:1449-1453.
38. Schultz, A.M., L.E. Henderson, and S. Oroszlan. 1988. Fatty acylation of proteins. Annu. Rev. Cell Biol. 4:611-647.
39. McIlhinney, R.A. 1990. The fats of life: the importance and function of protein acylation. Trends Biochem. Sci. 15:387-391.
40. Bourguignon, L.Y., E.L. Kalomiris, and V.B. Lokeshwar. 1991. Acylation of the lymphoma transmembrane glycoprotein, GPH5, may be required for GP85-ankyrin interaction. J. Biol. Chem. 266:11761-11765.
41. Guo, Y.J., S. Lin, J. Wang, M. Bigby, and M.S. Sy. 1994. Palmitoylation of CD44 interferes with CD3-mediated signaling in human T lymphocytes. Int. Immunol. 6:213-221.
42. Deng, W.P., and J.A. Nickoloff. 1992. Site-directed mutagenesis of virtually any plasmid by eliminating a unique site. Anal. Biochem. 200:81-88.
43. Hambor, J.E., C.A. Hauer, H.K. Sji, R.K. Groger, D.R. Kaplan, and M.L. Tykocinski. 1988. Use of an Epstein-Barr virus episomal replicon for anti-sense RNA mediated gene inhibition in a human cytotoxic T cell clone. Proc. Natl. Acad. Sci. USA. 85:4010-4014.
44. Ishihara, K., W.J. Wood, Jr., M. Damore, G.G. Hermanson, R. Wall, and P.W. Kincade. 1992. B29 gene products complex with inimunoglobulins on B lymphocytes. Proc. Natl. Acad. Sci. USA. 89:633-637.
45. De Beider, A.N., and K. Ove Wik. 1975. Preparation and properties of fluorescein-labeled hyaluronate. Carbohydrate Res. 44:251-257.
46. Geppert, T.D., and P.E. Lipsky. 1991. Association of various T cell surface molecules with the cytoskeleton. Effect of cross-linking and activation. J. Immunol. 146:3298-3305.
47. Parsey, M.V., and G. Lewis. 1993. Actin polymerization and pseudopod reorganization accompany anti-CD3 induced growth arrest injurkat T cells. J. Immunol, 151:1181-1893.